Harrow Health, 11875 Stock Price To Earning

HROWM Stock   26.20  0.08  0.31%   
Harrow Health, 11875 fundamentals help investors to digest information that contributes to Harrow Health,'s financial success or failures. It also enables traders to predict the movement of Harrow Stock. The fundamental analysis module provides a way to measure Harrow Health,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harrow Health, stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Harrow Health, 11875 Company Price To Earning Analysis

Harrow Health,'s Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Harrow Earnings Yield

Earnings Yield

(0.0305)

At this time, Harrow Health,'s Earnings Yield is very stable compared to the past year.
Based on the latest financial disclosure, Harrow Health, 11875 has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Specialty & Generic industry. The price to earning for all United States stocks is 100.0% higher than that of the company.

Harrow Health, Current Valuation Drivers

We derive many important indicators used in calculating different scores of Harrow Health, from analyzing Harrow Health,'s financial statements. These drivers represent accounts that assess Harrow Health,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Harrow Health,'s important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap626.0M640.1M661.4M688.7M841.5M883.6M
Enterprise Value642.0M659.4M697.2M704.7M957.9M1.0B

About Harrow Health, Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Harrow Health, 11875's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harrow Health, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harrow Health, 11875 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Harrow Health, 11875 is a strong investment it is important to analyze Harrow Health,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health,'s future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:
Check out Harrow Health, Piotroski F Score and Harrow Health, Altman Z Score analysis.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health,. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health, 11875 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health,'s value that differs from its market value or its book value, called intrinsic value, which is Harrow Health,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health,'s market value can be influenced by many factors that don't directly affect Harrow Health,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.